Safe and Effective Yoga Prescription of Seniors: Biomechanical Considerations
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 27
- 试验地点
- 2
- 主要终点
- peak joint moments
研究概览
简要总结
This is an Intervention Development Study (IDS) to quantify the physical demands (using biomechanical investigation) of a 2-phase (beginning & intermediate), 32-week yoga program designed for community-dwelling older adults. Additionally, the IDS will explore the adherence and adverse events of participation in the program. Data from the IDS will be used to develop evidenced-based yoga programs, which the investigators postulate will be associated with fewer musculoskeletal side effects compared to non-evidence based yoga programs. The investigators also postulate that evidenced-based tailoring of yoga for seniors will enhance adherence and efficacy. The programs developed during this IDS will be tested in an expanded, Phase II, Randomized Controlled Trial.
详细描述
Yoga is currently being recommended to restore and preserve strength, flexibility, balance, & physical capacity in older adults; however, our clinical trial experiences suggest that without proper evidenced-based prescription, Yoga participation can be ineffective or even injurious for seniors. To address this lack of evidence-based knowledge, the proposed IDS will: 1) quantify the physical demands of a 32-wk Yoga program designed for independent ambulatory seniors; 2) characterize the relations between these demands and participant physical characteristics; 3) examine the adherence, efficacy, & safety of the program; and 4) characterize the relations among reported adverse events, baseline participant characteristics, and Yoga physical demands.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Community dwelling men and women volunteers, aged 65 years or older.
排除标准
- •Safety exclusions:
- •-the following safety exclusions are adopted in order to decrease potential *cardiovascular
- •musculoskeletal
- •neurological risks to the participants:
- •active angina
- •uncontrolled hypertension (SBP greater than 160 or DBP greater than 90)
- •high resting pulse or respiratory rate (HR >90 or RR>24 after 5 minutes seated)
- •unstable asthma or exacerbated COPD
- •cervical spine instability or other significant neck injury
- •rheumatoid arthritis
- •unstable ankle, knee, hip, shoulder, elbow, or wrist joints
- •hemiparesis or paraparesis
- •movement disorders (e.g. Parkinson's disease), peripheral neuropathies, stroke with residual deficits, severe vision or hearing problems
- •walker or wheelchair use
- •insufficient hearing to permit safety in a yoga group setting
- •not able to attend in-person classes
- •has not had check-up by regular provider within 12 months (if not taking any prescription medications) or in the past 6 months (if any regular medicines taken); cannot pass specific movement safety tests (tests described in section on screening visits, below)
- •Feasibility/adherence exclusions:
- •unable to understand their commitment to the project, (laboratory visits & regular program participation)
- •cognitive limitations significant enough to preclude informed consent or to raise concerns about participation safety
结局指标
主要结局
peak joint moments
时间窗: difference from 16 wk to 32 wk
These are the torques produced by the muscles during performance of the yoga poses
次要结局
- number of heel-rise repetitions(baseline, 16 and 32 weeks)
- Time to complete Up & Go test(baseline, 16 and 32 weeks)
- time to stand and sit from a chair 5 times(baseline, 16 and 32 weeks)
- Number of marching steps completed within 2 minutes(baseline, 16 and 32 weeks)
- Distance participant can reach forward from a sitting position(baseline, 16 and 32 weeks)
- Distance between fingers of opposing hands as participant attempts to touch fingers while reaching posteriorly.(baseline, 16 and 32 weeks)
- Maximum passive wrist flexion, extension, radial-deviation, and ulnar-deviation, range of motion (in degrees).(baseline, 16 and 32 weeks)
- Maximum height participant can reach while standing(baseline, 16 and 32 weeks)
- Maximum distance participant can reach forward while standing(baseline, 16 and 32 weeks)
- stride length during walking(baseline, 16 and 32 weeks)
- Maximum joint angle(baseline, 16 and 32 weeks)
- Sway distance of the center of pressure(baseline, 16 and 32 weeks)
- Electromyographic activity of muscles(baseline, 16 and 32 weeks)
- SF-36 score(baseline and 36 weeks)
研究者
George Salem
Associate Professor
University of Southern California